Baloney Alzheimer’s Drugs Exposed in A New Study (and reveals real cures)

In November 2016, drug manufacturer Eli Lilly abandoned their attempts to test the drug Solanezumab, admitting that it had failed to halt even early stages of Alzheimer’s.

The problem wasn’t that the drug didn’t do what it was supposed to do, but that the underlying cause for Alzheimer’s most scientists work from is complete baloney.

They are, in essence, building the studies on sand rather than stone.

Because the minority of researchers, those who are more open to alternative solutions, have discovered much simpler, more common sense reason for Alzheimer’s, with a cure in sight.

Solanezumab works against amyloid proteins from blood and cerebrospinal fluid, thereby preventing it from being able to build up in the brain.

At this stage, many scientists believe that a buildup of amyloid proteins in the brain causes Alzheimer’s disease.

Even though this and many other trials have failed, many are still not prepared to let this amyloid hypothesis go.

As they told the journal Nature in December 2016, the problem is with the way Solanezumab works, not with the amyloid hypothesis itself.

It removes soluble amyloid from the blood, but it is possible that the amyloid that builds up in the brain is insoluble and comes from somewhere else.

Or it could simply be the case that, as another article in Nature stated, “just as cholesterol is not the sole cause of heart disease, amyloid is not the only driver of Alzheimer’s”.

Given that another drug trial, that of Merck’s drug, verubecestat, was declared a failure in February 2017, the anti-amyloid hypothesis crowd is becoming deafening.

Verubecestat does not extract already formed amyloid from the blood; it instead tries to interfere with the process that forms amyloid.

While it is not currently possible to decide beyond doubt whether the amyloid hypothesis is right or wrong, it is difficult to deny that all large drug trials that target amyloid have failed over the past two decades.

Neurology professor David Knopman told Bloomberg that removing amyloid when people already show the signed of dementia is obviously too late and that a treatment should be Based on previous research, scientists at the Mayo Clinic recommend regular exercise, as it combats heart disease, often a cause of Alzheimer’s.

Further, it increases the release of chemicals that protect our brains, and it helps to preserve the connections between brain cells that normally deteriorate as we age.

This shows that natural processes within our bodies can beat back Alzheimer’s, if we only give our brains the tools need to make it happen. That’s what our brain booster exercises do, safely and naturally. Find out more about them here…